{"id":"W4396587962","doi":"10.1158/1538-7445.sabcs23-po3-16-11","title":"Abstract PO3-16-11: Attrition rates from first- to third-line therapy in HER2+ metastatic breast cancer in Europe","year":2024,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Metastatic breast cancer; Medicine; Cancer; Breast cancer; Attrition; Oncology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009858096,0.0002090471,0.0005813683,0.001178192,0.000349332,0.001461351,0.0008996886,0.0005930024,0.001726934],"category_scores_gemma":[0.01938124,0.0001479916,0.00115563,0.002622959,0.00035693,0.000921654,0.001399736,0.0006580223,0.0004098586],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001299434,"about_ca_system_score_gemma":0.001262426,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006335204,"about_ca_topic_score_gemma":0.002885703,"domain_scores_codex":[0.9938644,0.002440987,0.0009666778,0.0009366442,0.001277076,0.0005142894],"domain_scores_gemma":[0.9769239,0.004676401,0.01398472,0.00123972,0.00206008,0.001115312],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0007646764,0.00005847395,0.9923609,0.0000480039,0.0001416299,0.00003142749,0.0001285636,0.0001375879,0.00004311044,0.00004232332,0.0005852787,0.005658053],"study_design_scores_gemma":[0.00006899959,0.0003654897,0.9959564,0.00008436238,0.00009524302,0.0002748971,0.0003421512,0.0007379656,0.0001861795,0.00005380538,0.001825662,0.000008924761],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9940071,0.0008097551,0.0003250789,0.000213967,0.00001338898,0.00004306368,0.003650729,0.00001467892,0.000922162],"genre_scores_gemma":[0.9947855,0.0002898799,0.0002011458,0.0001850621,0.00002020414,0.00007185918,0.00414472,0.00001183555,0.0002898829],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009858096,"threshold_uncertainty_score":0.05213523,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1729663906008388,"score_gpt":0.5016200254026022,"score_spread":0.3286536348017634,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}